LEADER 05216nam 22006255 450 001 9910298399503321 005 20200701055601.0 010 $a3-319-93485-6 024 7 $a10.1007/978-3-319-93485-3 035 $a(CKB)4100000006519882 035 $a(MiAaPQ)EBC5515253 035 $a(DE-He213)978-3-319-93485-3 035 $a(PPN)230539114 035 $a(EXLCZ)994100000006519882 100 $a20180912d2018 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHuman Neural Stem Cells $eFrom Generation to Differentiation and Application /$fedited by Leonora Buzanska 205 $a1st ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (334 pages) 225 1 $aResults and Problems in Cell Differentiation,$x0080-1844 ;$v66 311 $a3-319-93484-8 327 $aPart 1. Derivation and/or generation of human neural stem cells -- 1. Derivation of neural stem cells from the developing and adult human brain -- 2. Comparison of after-birth and adult somatic tissues in ability to generate human neural stem cells -- 3. Neural stem cells derived from human induced pluripotent stem cells and their use in models of CNS injury -- 4. Generation of human neural stem cells by direct phenotypic conversion -- Part 2. Differentiation and underlying mechanisms -- 5. Epigenetic regulation of human neural stem cell differentiation -- 6. Human iPSC-derived neuronal committed cells reveal common developmental genome deprograming in schizophrenia -- 7. Genome editing in human neural stem and progenitor cells -- 8. Brain Organoids ? expanding our understanding of human development and disease -- 9. Microenvironmental cues in human neural stem cell fate commitment -- Part 3. Therapeutic potential of human neural stem cells -- 10. Updates on Human Neural Stem Cells: From Generation, Maintenance and Differentiation to Research and Translational Applications -- 11. Human neural stem cells for ischemic stroke treatment -- 12. Modeling pediatric and neuropsychiatric diseases using human iPSC -- 13. Neural stem cell dysfunction in human brain diseases -- 14. Human Fetal Neural Stem Cells for neurodegenerative disease treatment. 330 $aThis book summarizes early pioneering achievements in the field of human neural stem cell (hNSC) research and combines them with the latest advances in stem cell technology, including reprogramming and gene editing. The powerful potential of hNSC to generate and repair the developing and adult CNS has been confirmed by numerous experimental in vitro and in vivo studies. The book presents methods for hNSC derivation and discusses the mechanisms underlying NSC in vitro fate decisions and their in vivo therapeutic mode of action. The long-standing dogma that the human central nervous system (CNS) lacks the ability to regenerate was refuted at the end of the 20th century, when evidence of the presence of neurogenic zones in the adult human brain was found. These neurogenic zones are home to human neural stem cells (hNSCs), which are capable of self-renewing and differentiating into neurons, astrocytes and oligodendrocytes. NSCs isolated from human CNS have a number of clinical advantages, especially the innate potential to differentiate into functional neural cells. Nevertheless, their full clinical exploitation has been hindered by limited access to the tissue and low expansion potential. The search for an alternative to CNS sources of autologous, therapeutically competent hNSCs was the driving force for the many studies proving the in vitro plasticity of different somatic stem cells to generate NSCs and their functional progeny. Now the era of induced pluripotent stem cells has opened entirely new opportunities to achieve research and therapeutic goals with the aid of hNSCs. 410 0$aResults and Problems in Cell Differentiation,$x0080-1844 ;$v66 606 $aStem cells 606 $aMedical genetics 606 $aNeurosciences 606 $aGene therapy 606 $aCytogenetics 606 $aStem Cells$3https://scigraph.springernature.com/ontologies/product-market-codes/L16010 606 $aGene Function$3https://scigraph.springernature.com/ontologies/product-market-codes/B12030 606 $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006 606 $aGene Therapy$3https://scigraph.springernature.com/ontologies/product-market-codes/B12020 606 $aCytogenetics$3https://scigraph.springernature.com/ontologies/product-market-codes/B12040 615 0$aStem cells. 615 0$aMedical genetics. 615 0$aNeurosciences. 615 0$aGene therapy. 615 0$aCytogenetics. 615 14$aStem Cells. 615 24$aGene Function. 615 24$aNeurosciences. 615 24$aGene Therapy. 615 24$aCytogenetics. 676 $a612.64018 702 $aBuzanska$b Leonora$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298399503321 996 $aHuman Neural Stem Cells$92508885 997 $aUNINA